Piper Sandler analyst David Westenberg lowered the firm’s price target on Neogen (NEOG) to $13 from $16.50 and keeps a Neutral rating on the shares following the company’s earnings report. The firm notes that its change in price target primarily reflects its updated estimates and updated multiple.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on NEOG: